Heme biosynthesis
REACTOME PATHWAYThe Heme biosynthesis pathway (Reactome ID: R-HSA-189451) involves 3 genes and is affected by 35 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Heme biosynthesis
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | licochalcone | — | 267 |
| 2 | Quercetin | — | 300 |
| 3 | Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is | — | 300 |
| 4 | Apigenin 5,7,4'-trihydroxy-flavone, | — | 300 |
| 5 | chrysin | — | 300 |
| 6 | Genistein | — | 300 |
| 7 | Kaempferols | — | 300 |
| 8 | 3',4'-didemethylnobiletin [Supplementary Concept] | — | 300 |
| 9 | Atorvastatin | — | 1,000 |
| 10 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | — | 150 |
| 11 | Sirolimus | — | 300 |
| 12 | Avapritinib | — | 246 |
| 13 | candesartan cilexetil [Supplementary Concept] | — | 300 |
| 14 | Caspofungin | — | 299 |
| 15 | Daunorubicin | — | 298 |
| 16 | Delavirdine | — | 296 |
| 17 | Estrone | — | 300 |
| 18 | Febuxostat | — | 297 |
| 19 | Fenofibrate | — | 297 |
| 20 | Furosemide | — | 298 |
| 21 | Sorafenib | — | 300 |
| 22 | Topotecan | — | 300 |
| 23 | Warfarin | — | 1,000 |
| 24 | Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of | — | 300 |
| 25 | Tolbutamide | — | 300 |
| 26 | cbd | — | 298 |
| 27 | egcg | — | 300 |
| 28 | cannabidiol | — | 296 |
| 29 | Catechin | — | 300 |
| 30 | Evans Blue | — | 300 |
| 31 | Olmesartan Medoxomil | — | 300 |
| 32 | Phenylbutazone | — | 300 |
| 33 | Trazodone | — | 297 |
| 34 | Vemurafenib | — | 298 |
| 35 | Axitinib | — | 298 |
About the Heme biosynthesis Pathway
The Heme biosynthesis pathway is catalogued in Reactome (ID: R-HSA-189451) and involves 3 genes. In the BiohacksAI corpus, 35 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ABCG2, ALB, FECH.